Market Overview:
The global Ambulatory Infusion Center Market is estimated to be valued at US$
47,013.5 million in 2020 and is expected to reach US$ 47,013.5 million by 2022,
exhibiting a CAGR of 9.0% over the forecast period (2020-2027). Ambulatory
infusion centers provide various medical services, including infusion therapy,
blood transfusion, and pain management. These centers offer numerous advantages
such as convenience, reduced hospital stays, cost-effectiveness, and
personalized patient care. The need for ambulatory infusion centers has grown
due to the rising prevalence of chronic diseases, increasing demand for
advanced healthcare facilities, and the shift towards value-based care.
Market Key Trends:
One key trend in the Ambulatory Infusion Center Market is the growing
preference for home-based infusion therapy. Home-based infusion therapy allows
patients to receive necessary medications in the comfort of their own homes,
reducing healthcare costs and improving patient satisfaction. The increasing
aging population, rising prevalence of chronic diseases, and advancements in
medical technology have facilitated the growth of home-based infusion therapy.
This trend is transforming the healthcare landscape by encouraging the
development of innovative solutions and expanding the reach of healthcare
services to patients' homes. Companies in the market are investing in
technologies and services that support home-based infusion therapy, resulting
in improved patient outcomes and reduced healthcare burden.
Segment Analysis:
The Ambulatory Infusion Center market can be segmented based on the type of
therapy, which includes chemotherapy, antibiotic therapy, pain management,
hydration therapy, and others. Among these segments, chemotherapy is expected
to dominate the market during the forecast period. This can be attributed to
the increasing incidence of cancer globally and the growing need for
chemotherapy treatment. According to the World Health Organization (WHO),
cancer is one of the leading causes of death worldwide, accounting for 9.6
million deaths in 2018. The demand for ambulatory infusion centers for
chemotherapy treatment is expected to rise significantly as they offer
convenience, reduced healthcare costs, and personalized care.
Key Takeaways:
Market size: The
global
Ambulatory Infusion Center market is expected to witness high growth,
exhibiting a CAGR of 9.0% over the forecast period. The market was valued at
US$ 47,013.5 million in 2020. This growth can be attributed to various factors
such as the increasing prevalence of chronic diseases, advancements in
healthcare technology, and the rising demand for outpatient care.
Regional analysis: North America is expected to be the fastest-growing and
dominating region in the Ambulatory Infusion Center market. This can be
attributed to the well-established healthcare infrastructure, high adoption of
advanced technologies, and the presence of key market players in the region.
Additionally, factors such as the increasing prevalence of cancer and the
rising demand for efficient and cost-effective healthcare services are driving
the growth of the market in North America.
Key players: Key players operating in the Ambulatory Infusion Center market
include Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health,
Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health,
PharMerica, Beacon Health System, Inc., Arnot Health, Inc., IVX Health, and
Precision Healthcare. These players are focusing on strategic partnerships,
acquisitions, and product launches to strengthen their market presence and
expand their product portfolios. Additionally, they are investing in research
and development activities to develop innovative solutions and gain a
competitive edge in the market.
Read More:
https://www.ukwebwire.com/ambulatory-infusion-center-market-growing-demand-for-outpatient-infusion-services-drives-market-growth/
Comments
Post a Comment